Technology
“Towards Clinical Application of L-glucose” issued by Dr. Katsuya Yamada
Dr. Katsuya Yamada, CMO at ORBIO, was invited to publish our research on L-glucose entitled “Towards Clinical Application of L-Glucose” on the journal of The Japanese Society of Applied Glycoscience 12: 140-154 (2022). A part of this study was presented on The 2021 Japanese Society of Applied Glycoscience Symposium. This paper suggests the possibility of applying L-glucose as a drug delivery system for an anti-cancer drug, which we are focusing on.